Marie Attwood, BSc

North Bristol NHS Trust, United Kingdom

Disclosure(s): No financial relationships to disclose

Poster(s):

• 617 - Pharmacodynamics of Ceftolozane-Tazobactam (C/T) as Monotherapy and in Combination with Tobramycin or Fosfomycin Against P.aeruginosa with C/T MICs at or Above 4mg/L
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET